about
The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-AA novel neutralizing antibody targeting pregnancy-associated plasma protein-a inhibits ovarian cancer growth and ascites accumulation in patient mouse tumorgraftsThe structural basis of calcium transport by the calcium pumpComplex of pregnancy-associated plasma protein-A and the proform of eosinophil major basic protein. Disulfide structure and carbohydrate attachmentLocalization of disulfide bridges and free sulfhydryl groups in human eosinophil granule major basic proteinComplete cDNA sequence of the preproform of human pregnancy-associated plasma protein-A. Evidence for expression in the brain and induction by cAMPLocation and nature of carbohydrate groups in proform of human major basic protein isolated from pregnancy serumIdentification of angiotensinogen and complement C3dg as novel proteins binding the proform of eosinophil major basic protein in human pregnancy serum and plasmaCirculating human pregnancy-associated plasma protein-A is disulfide-bridged to the proform of eosinophil major basic proteinExpression of recombinant murine pregnancy-associated plasma protein-A (PAPP-A) and a novel variant (PAPP-Ai) with differential proteolytic activityPregnancy-associated plasma protein-A (PAPP-A) cleaves insulin-like growth factor binding protein (IGFBP)-5 independent of IGF: implications for the mechanism of IGFBP-4 proteolysis by PAPP-AIdentification of transglutaminase reactive residues in human osteopontin and their role in polymerizationRare and low-frequency coding variants alter human adult heightDuplication and diversification of the hypoxia-inducible IGFBP-1 gene in zebrafishCalmodulin mutations causing catecholaminergic polymorphic ventricular tachycardia confer opposing functional and biophysical molecular changes.Indirect targeting of IGF receptor signaling in vivo by substrate-selective inhibition of PAPP-A proteolytic activityAn isolated, surface-expressed I domain of the integrin alphaLbeta2 is sufficient for strong adhesive function when locked in the open conformation with a disulfide bond.Haptoglobin-related protein is a high-affinity hemoglobin-binding plasma protein.Pregnancy-associated plasma protein-A expression in human breast cancer.Molecular cloning and characterization of porcine Na⁺/K⁺-ATPase isoforms α1, α2, α3 and the ATP1A3 promoter.Stanniocalcin-2 inhibits mammalian growth by proteolytic inhibition of the insulin-like growth factor axis.The role of PAPP-A in the IGF system: location, location, location.Stanniocalcin-1 Potently Inhibits the Proteolytic Activity of the Metalloproteinase Pregnancy-associated Plasma Protein-A.Transglutaminase 2-Catalyzed Intramolecular Cross-Linking of Osteopontin.PAPP-A proteolytic activity enhances IGF bioactivity in ascites from women with ovarian carcinomaLactation opposes pappalysin-1-driven pregnancy-associated breast cancer.Mutations in pregnancy-associated plasma protein A2 cause short stature due to low IGF-I availability.Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2.Conformational changes in tertiary structure near the ligand binding site of an integrin I domain.Mice deficient in PAPP-A show resistance to the development of diabetic nephropathyPAPP-A: a promising therapeutic target for healthy longevity.Biology of pregnancy-associated plasma protein-A in relation to prenatal diagnostics: an overview.Zebrafish as a novel model to assess Na+/K(+)-ATPase-related neurological disorders.PAPP-A and the IGF system.The proteolytic activity of pregnancy-associated plasma protein-A is potentially regulated by stanniocalcin-1 and -2 during human ovarian follicle development.Temporal course of pregnancy-associated plasma protein-A in angioplasty-treated ST-elevation myocardial infarction patients and potential significance of concomitant heparin administration.Pregnancy-Associated Plasma Protein-A2 and Anthropometry, Lifestyle, and Biochemical Factors in a Human Adult Population.The IGF system in patients with type 2 diabetes: associations with markers of cardiovascular target organ damage.Stress-activated signaling pathways mediate the stimulation of pregnancy-associated plasma protein-A expression in cultured human fibroblasts.Real-time measurement in living cells of insulin-like growth factor activity using bioluminescence resonance energy transfer.
P50
Q22009032-2E178641-DF04-41F5-B6A3-542AFB61E022Q27346392-C751231C-8438-40F9-98FD-DE3DD9FF2B32Q27649288-16FD1FB5-831A-4052-9676-7127AE5AF040Q28214228-A85B0A3A-1F20-4E39-B228-3E8346F172F0Q28251058-966368AF-0FA4-4560-A3C2-F23393E54D6AQ28277527-F895CE0D-48E7-41EE-A453-CEE0332D815BQ28286985-858B5D19-0CD0-4D13-8C7E-443BD4310802Q28287991-A865FB99-1A79-44BD-9DE9-15FD8E25077DQ28298024-69E91524-F8E2-4161-871F-F1B8EF52DCE1Q28510464-97B1CB96-FE80-442B-8810-263D5F19C9E9Q28616725-5752216E-42EF-49BE-A680-8C3E7AE7943FQ28651507-55A0887B-DBFD-4691-BC7A-48745BAEFFDEQ29583867-B4AD1668-6099-4BE8-8502-FD7441D8EAC8Q30371857-21ACA75F-E09B-47D1-ADBF-1EBE7EC8949FQ33165145-72A6D5CB-9A75-4D67-BE45-8560E8DFC340Q33572235-A4335EF2-A185-463B-87A9-839121947774Q34461123-723459E4-52A3-4F5B-9409-71A080187DDAQ34538761-66567691-AD29-48BE-B13A-2B1B985C6B45Q35019711-5AE2F854-428C-4EBC-A76E-9506738A5D91Q35043709-DD7417BD-A4E3-482E-96A2-C3B64622821BQ35055523-5DDA6CC6-9D73-4641-B35F-7103BE763C02Q35690633-CAC214C2-299B-41F4-9566-325F3175A7B3Q35701645-8C2FBB00-EB37-4CD8-86A8-4BD1964E9756Q35871801-76B54894-C2F9-4AC5-A364-E62BE7832F99Q36544836-D57D950C-03ED-4DFA-BFC1-DAFE4D5F269CQ36759471-61ABC8B6-A2F9-449B-9DD7-0CA5667035CDQ36759492-6F830994-9F6E-4064-8BDA-AB814299C30FQ37072792-3E7AAFF8-DF2C-4391-A3AF-06B8249DEE26Q37177172-E6121BD1-5D4E-4DFC-A1F5-1660053AE609Q37286585-BEEB5764-99E2-4727-8F40-90EBFEF78A95Q37678178-D4E34B61-CF1A-4961-9F49-671EDB272595Q37784027-A10FF9FC-2A90-406C-99B1-AAC2CF0F4CA4Q38148884-9EE5B045-A687-46E6-8E34-2BEA24823702Q38828333-E7333867-270D-4BBD-9F1F-2043FA9B24F2Q38908472-AEA04A4D-2241-4FD1-AE9F-AF13448488A7Q40016673-6DC64349-636E-46C2-88A8-66307F14B3CAQ40056700-50739809-C187-494D-BFD4-3C6456BA031CQ40343696-D568C1FB-F15A-4389-AE5B-4C2EBDCA47EAQ40354884-0FFF135F-99E9-466D-A1BC-A8357ECED9DAQ40413764-22AE5DDA-E410-4B79-A86F-617657FC25D8
P50
description
researcher
@en
researcher
@en-gb
wetenschapper
@nl
հետազոտող
@hy
name
Claus Oxvig
@ast
Claus Oxvig
@en
Claus Oxvig
@en-gb
Claus Oxvig
@es
Claus Oxvig
@nl
Claus Oxvig
@sl
type
label
Claus Oxvig
@ast
Claus Oxvig
@en
Claus Oxvig
@en-gb
Claus Oxvig
@es
Claus Oxvig
@nl
Claus Oxvig
@sl
prefLabel
Claus Oxvig
@ast
Claus Oxvig
@en
Claus Oxvig
@en-gb
Claus Oxvig
@es
Claus Oxvig
@nl
Claus Oxvig
@sl
P106
P31
P496
0000-0002-4715-9719